Evidence map›Paper›PMID 27098315›Full record

ArticleCellular and molecular neurobiology2017

Minocycline Promotes Neurite Outgrowth of PC12 Cells Exposed to Oxygen-Glucose Deprivation and Reoxygenation Through Regulation of MLCP/MLC Signaling Pathways.

Tao Tao, Jin-Zhou Feng, Guang-Hui Xu, Jie Fu, Xiao-Gang Li, Xin-Yue Qin

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular neurobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Protective Role of Astrocyte-Derived ExosomalNeuropsychiatric disease and treatment · 2020
    Article
  7. Electroacupuncture Ameliorates Cerebral I/R-Induced Inflammation through DOR-BDNF/TrkB Pathway.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tao TaoDepartment of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, 64600, Sichuan Province, China.
Jin-Zhou FengDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Guang-Hui XuDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Jie FuDepartment of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, 64600, Sichuan Province, China.
Xiao-Gang LiDepartment of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou, 64600, Sichuan Province, China.
Xin-Yue QinDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. qinxinyue@sina.com.
Affiliated Hospital of Southwest Medical University · CNChongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Minocycline, a semi-synthetic second-generation derivative of tetracycline, has been reported to exert neuroprotective effects both in animal models and in clinic trials of neurological diseases. In the present study, we first investigated the protective effects of minocycline on oxygen-glucose deprivation and reoxygenation-induced impairment of neurite outgrowth and its potential mechanism in the neuronal cell line, PC12 cells. We found that minocycline significantly increased cell viability, promoted neurite outgrowth and enhanced the expression of growth-associated protein-43 (GAP-43) in PC12 cells exposed to oxygen-glucose deprivation/reoxygenation injury. In addition, immunoblots revealed that minocycline reversed the overexpression of phosphorylated myosin light chain (MLC) and the suppression of activated extracellular signal-regulated kinase 1/2 (ERK1/2) caused by oxygen-glucose deprivation/reoxygenation injury. Moreover, the minocycline-induced neurite outgrowth was significantly blocked by Calyculin A (1 nM), an inhibitor of myosin light chain phosphatase (MLCP), but not by an ERK1/2 inhibitor (U0126; 10 μM). These findings suggested that minocycline activated the MLCP/MLC signaling pathway in PC12 cells after oxygen-glucose deprivation/reoxygenation injury, which resulted in the promotion of neurite outgrowth.

Indexed as

AnimalsCell DeathCell SurvivalEnzyme ActivationExtracellular Signal-Regulated MAP KinasesGAP-43 ProteinGlucoseMinocyclineMyosin-Light-Chain PhosphataseMyosin Light ChainsNeuritesOxygenPC12 CellsPhosphorylationRatsExtracellular Signal-Regulated MAP KinasesGAP-43 ProteinGlucoseMinocyclineMyosin-Light-Chain PhosphataseMyosin Light ChainsOxygenMinocyclineMyosin light chainNeurite outgrowthOxygen-glucose deprivation and reoxygenationPC12 cells

Identifiers

PMID27098315
PMCPMC11482204
OpenAlexW2340116713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.